In the BioHarmony Drug Report Database

"Preview" Icon

Cerliponase alfa

Brineura (cerliponase alfa) is an enzyme pharmaceutical. Cerliponase alfa was first approved as Brineura on 2017-04-27. It is used to treat neuronal ceroid-lipofuscinoses in the USA. It has been approved in Europe to treat neuronal ceroid-lipofuscinoses.

 

Trade Name

 

Brineura
 

Common Name

 

cerliponase alfa
 

ChEMBL ID

 

CHEMBL3544921
 

Indication

 

neuronal ceroid-lipofuscinoses
 

Drug Class

 

Enzymes

Image (chem structure or protein)

Cerliponase alfa structure rendering